Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

666 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The transcription factor BACH2 promotes tumor immunosuppression.
Roychoudhuri R, Eil RL, Clever D, Klebanoff CA, Sukumar M, Grant FM, Yu Z, Mehta G, Liu H, Jin P, Ji Y, Palmer DC, Pan JH, Chichura A, Crompton JG, Patel SJ, Stroncek D, Wang E, Marincola FM, Okkenhaug K, Gattinoni L, Restifo NP. Roychoudhuri R, et al. Among authors: gattinoni l. J Clin Invest. 2016 Feb;126(2):599-604. doi: 10.1172/JCI82884. Epub 2016 Jan 5. J Clin Invest. 2016. PMID: 26731475 Free PMC article.
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells.
Klebanoff CA, Finkelstein SE, Surman DR, Lichtman MK, Gattinoni L, Theoret MR, Grewal N, Spiess PJ, Antony PA, Palmer DC, Tagaya Y, Rosenberg SA, Waldmann TA, Restifo NP. Klebanoff CA, et al. Among authors: gattinoni l. Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1969-74. doi: 10.1073/pnas.0307298101. Epub 2004 Feb 4. Proc Natl Acad Sci U S A. 2004. PMID: 14762166 Free PMC article.
Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer.
Finkelstein SE, Heimann DM, Klebanoff CA, Antony PA, Gattinoni L, Hinrichs CS, Hwang LN, Palmer DC, Spiess PJ, Surman DR, Wrzesiniski C, Yu Z, Rosenberg SA, Restifo NP. Finkelstein SE, et al. Among authors: gattinoni l. J Leukoc Biol. 2004 Aug;76(2):333-7. doi: 10.1189/jlb.0304120. Epub 2004 May 20. J Leukoc Biol. 2004. PMID: 15155774 Free PMC article.
Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumor destruction.
Palmer DC, Balasubramaniam S, Hanada K, Wrzesinski C, Yu Z, Farid S, Theoret MR, Hwang LN, Klebanoff CA, Gattinoni L, Goldstein AL, Yang JC, Restifo NP. Palmer DC, et al. Among authors: gattinoni l. J Immunol. 2004 Dec 15;173(12):7209-16. doi: 10.4049/jimmunol.173.12.7209. J Immunol. 2004. PMID: 15585842 Free PMC article.
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells.
Klebanoff CA, Gattinoni L, Torabi-Parizi P, Kerstann K, Cardones AR, Finkelstein SE, Palmer DC, Antony PA, Hwang ST, Rosenberg SA, Waldmann TA, Restifo NP. Klebanoff CA, et al. Among authors: gattinoni l. Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9571-6. doi: 10.1073/pnas.0503726102. Epub 2005 Jun 24. Proc Natl Acad Sci U S A. 2005. PMID: 15980149 Free PMC article.
Programming CD8+ T cells for effective immunotherapy.
Hinrichs CS, Gattinoni L, Restifo NP. Hinrichs CS, et al. Among authors: gattinoni l. Curr Opin Immunol. 2006 Jun;18(3):363-70. doi: 10.1016/j.coi.2006.03.009. Epub 2006 Apr 17. Curr Opin Immunol. 2006. PMID: 16616471 Free PMC article. Review.
Adoptive immunotherapy for cancer: building on success.
Gattinoni L, Powell DJ Jr, Rosenberg SA, Restifo NP. Gattinoni L, et al. Nat Rev Immunol. 2006 May;6(5):383-93. doi: 10.1038/nri1842. Nat Rev Immunol. 2006. PMID: 16622476 Free PMC article. Review.
666 results